About Blake Richards
Blake Richards is chief operating officer of Elucid, a Boston company that makes AI software to read plaque in heart and neck arteries on CT scans. Before that, Richards was Elucid's chief executive officer, until the company named Kelly Huang to the role in July 2024. The company's releases quote him in that role from at least November 2022 through November 2023.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Blake Richards in the role, so the role may have started earlier or lasted longer.
Elucid Bioimaging Inc. Current
Chief Operating Officer
Chief Executive Officer (2024)
2023 – Present · Boston, MA
Elucid makes AI software that measures plaque in heart and neck arteries from CT scans to help doctors choose treatment.
Key Colleagues at Startups
The people Blake Richards works with at each company, as listed on that company's latest Form D.
Elucid Bioimaging Inc. · Form D/A, Oct 27, 2026
Scott Huennekens
Chairman of the Board
ML
Michael Lesh
Director
RK
Richard Kuntz
Director
EM
Evan Melrose
Director
SF
Shamiram Feinglass
Director
Kelly Huang
President and Chief Executive Officer, director
RP
Rajesh Panda
Director
Blake Richards in the News
Sources
- SECElucid Bioimaging Inc. Form D/A, filed Oct 27, 2026
- PressElucid names Kelly Huang as CEO, with Blake Richards continuing as COO (July 22, 2024)
- PressElucid Series C release quoting CEO Blake Richards (November 9, 2023)
- PressElucid appoints Dr. Michael Lesh to its board, quoting CEO Blake Richards (November 3, 2022)